{"title":"Neuropeptide Y neurons in the basolateral amygdala project to the nucleus accumbens and stimulate high-fat intake.","authors":"Shunji Yamada, Kazunori Kojima, Masaki Tanaka","doi":"10.3389/fncel.2025.1565939","DOIUrl":null,"url":null,"abstract":"<p><p>Neuropeptide Y (NPY) is a 36-amino acid neuropeptide that is widely expressed in the central nervous system, including in the nucleus accumbens (NAc), hypothalamus, and amygdala. The NAc involved in several behaviors, including reward, motivation processes, and feeding behavior. Here, we demonstrate in male mice that NPY input from the basolateral amygdala (BLA) to the NAc is involved in the preferential consumption of a high-fat diet (HFD). First, we demonstrated the NPY input to the NAc from the BLA by injecting adeno-associated virus (AAV)(retro)-FLEX-mCherry into the NAc of NPY-Cre mice. We also confirmed that BLA NPY neurons project exclusively to the NAc by injecting AAV(dj)-hSyn-FLEx -mGFP-2A-Synaptophysin-mRuby into the BLA. Usually, a HFD drives enhanced food intake than a standard chow diet after repetitive exposure. The optogenetic inactivation of BLA NPY neurons projecting to the NAc caused a significant decrease in HFD intake for a 1-h period, while optogenetic activation of these neurons induced the opposite effect. Furthermore, bilateral injection of an NPY receptor type 1 (Y1R) antagonist into the NAc significantly decreased HFD intake for 1-h period compared with vehicle injection, while, conversely, injection of a Y1R agonist enhanced HFD intake. These results suggest that BLA NPY neurons projecting to the NAc mediate preferential HFD intake via NAc-localized Y1R.</p>","PeriodicalId":12432,"journal":{"name":"Frontiers in Cellular Neuroscience","volume":"19 ","pages":"1565939"},"PeriodicalIF":4.2000,"publicationDate":"2025-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11983651/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Cellular Neuroscience","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fncel.2025.1565939","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Neuropeptide Y (NPY) is a 36-amino acid neuropeptide that is widely expressed in the central nervous system, including in the nucleus accumbens (NAc), hypothalamus, and amygdala. The NAc involved in several behaviors, including reward, motivation processes, and feeding behavior. Here, we demonstrate in male mice that NPY input from the basolateral amygdala (BLA) to the NAc is involved in the preferential consumption of a high-fat diet (HFD). First, we demonstrated the NPY input to the NAc from the BLA by injecting adeno-associated virus (AAV)(retro)-FLEX-mCherry into the NAc of NPY-Cre mice. We also confirmed that BLA NPY neurons project exclusively to the NAc by injecting AAV(dj)-hSyn-FLEx -mGFP-2A-Synaptophysin-mRuby into the BLA. Usually, a HFD drives enhanced food intake than a standard chow diet after repetitive exposure. The optogenetic inactivation of BLA NPY neurons projecting to the NAc caused a significant decrease in HFD intake for a 1-h period, while optogenetic activation of these neurons induced the opposite effect. Furthermore, bilateral injection of an NPY receptor type 1 (Y1R) antagonist into the NAc significantly decreased HFD intake for 1-h period compared with vehicle injection, while, conversely, injection of a Y1R agonist enhanced HFD intake. These results suggest that BLA NPY neurons projecting to the NAc mediate preferential HFD intake via NAc-localized Y1R.
期刊介绍:
Frontiers in Cellular Neuroscience is a leading journal in its field, publishing rigorously peer-reviewed research that advances our understanding of the cellular mechanisms underlying cell function in the nervous system across all species. Specialty Chief Editors Egidio D‘Angelo at the University of Pavia and Christian Hansel at the University of Chicago are supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.